Appendix 4C Quarterly Activity Report for Quarter Ended December 31, 2023 – StreetInsider.com

Second Phase 3 trial underway for rexlemestrocel-L in the treatment of chronic low back pain (CLBP) due to inflammatory disc degeneration– a condition …
Source: back pain